Although several studies have shown that higher levels of NT-proBNP at the time of PE diagnosis corelate with increased mortality, its prognostic utility may be limited by patient characteristics such as age, obesity, chronic cardiac conditions, and renal failure [29–31]. Here, NPPB is linked to obesity due to melanocortin 4 receptor deficiency.